Kodiak Sciences Analyst Price Targets

Wall Street analyst price targets and consensus rating for Kodiak Sciences (KOD).

Price Target Range — 10 Quarters

Analyst Consensus — 8 Analysts

7Buy

1Hold

Consensus RatingBuy# Analysts8Avg. Consensus PT$53Upside to Avg. PT-42.6%

Rating Trend — Last 9 Months

Recent Analyst Actions

すべての評価を見る →

Date	Firm	Analyst	Action	Rating Change	Price Target
Sep 28, 2026	LifeSci Capital	Patrick Dolezal	PT Raise	Outperform	$85→$145
Sep 28, 2026	UBS	Michael Yee	PT Raise	Buy	$80→$120
Sep 28, 2026	HC Wainwright & Co.	Matthew Caufield	PT Raise	Buy	$58→$96
Sep 24, 2026	Goldman Sachs	Andrea Newkirk	Reinstates	Neutral	$36
Sep 17, 2026	HC Wainwright & Co.	Matthew Caufield	Maintained	Buy	$58
Aug 17, 2026	HC Wainwright & Co.	Matthew Caufield	Maintained	Buy	$58
Aug 3, 2026	JP Morgan	Anupam Rama	PT Raise	Overweight	$56→$66
May 11, 2026	Chardan Capital	Daniil Gataulin	Upgrade	Neutral→Buy	$14→$61
Mar 27, 2026	UBS	Michael Yee	PT Raise	Buy	$50→$80
Mar 27, 2026	HC Wainwright & Co.	Matthew Caufield	PT Raise	Buy	$38→$58
Feb 10, 2026	HC Wainwright & Co.	Matthew Caufield	Maintained	Buy	$38
Jan 22, 2026	HC Wainwright & Co.	Matthew Caufield	PT Raise	Buy	$26→$38
Jan 7, 2026	UBS	Michael Yee	Initiate	Buy	$50
Nov 17, 2025	Chardan Capital	Daniil Gataulin	Maintained	Neutral	$14
Nov 17, 2025	HC Wainwright & Co.	Matthew Caufield	PT Raise	Buy	$24→$26
Nov 11, 2025	HC Wainwright & Co.	Matthew Caufield	Upgrade	Neutral→Buy	$5→$24
Oct 24, 2025	JP Morgan	Anupam Rama	Upgrade	Neutral→Overweight	$15→$24
Oct 23, 2025	LifeSci Capital	Patrick Dolezal	Initiate	Outperform	$40
Oct 6, 2025	Chardan Capital	Daniil Gataulin	Maintained	Neutral	$14
Sep 25, 2025	Barclays	Gena Wang	Upgrade	Underweight→Equal-Weight	$7→$17

More with Benzinga EdgeGet Access

Analyst Ratings News

PRO
UBS Maintains Buy on Kodiak Sciences, Raises Price Target to $120

UBS analyst Michael Yee maintains Kodiak Sciences (NASDAQ:KOD) with a Buy and raises the price target from $80 to $120.

Benzinga Newsdesk

PRO
HC Wainwright & Co. Maintains Buy on Kodiak Sciences, Raises Price Target to $96

HC Wainwright & Co. analyst Matthew Caufield maintains Kodiak Sciences (NASDAQ:KOD) with a Buy and raises the price target from $58 to $96.

Benzinga Newsdesk

PRO
Goldman Sachs Reinstates Neutral on Kodiak Sciences, Announces $36 Price Target

Goldman Sachs analyst Andrea Newkirk reinstates Kodiak Sciences (NASDAQ:KOD) with a Neutral and announces $36 price target.

Benzinga Newsdesk

PRO
HC Wainwright & Co. Reiterates Buy on Kodiak Sciences, Maintains $58 Price Target

HC Wainwright & Co. analyst Matthew Caufield reiterates Kodiak Sciences (NASDAQ:KOD) with a Buy and maintains $58 price target.

Benzinga Newsdesk

PRO
HC Wainwright & Co. Reiterates Buy on Kodiak Sciences, Maintains $58 Price Target

HC Wainwright & Co. analyst Matthew Caufield reiterates Kodiak Sciences (NASDAQ:KOD) with a Buy and maintains $58 price target.

Benzinga Newsdesk

PRO
JP Morgan Maintains Overweight on Kodiak Sciences, Raises Price Target to $66

JP Morgan analyst Anupam Rama maintains Kodiak Sciences (NASDAQ:KOD) with a Overweight and raises the price target from $56 to $66.

Benzinga Newsdesk

Kodiak Sciences Inc

ニュース

パートナーシップ

ベンジンガ・グローバル

Kodiak Sciences Analyst Price Targets

Recent Analyst Actions

Analyst Ratings News

PRO
UBS Maintains Buy on Kodiak Sciences, Raises Price Target to $120

PRO
HC Wainwright & Co. Maintains Buy on Kodiak Sciences, Raises Price Target to $96

PRO
Goldman Sachs Reinstates Neutral on Kodiak Sciences, Announces $36 Price Target

PRO
HC Wainwright & Co. Reiterates Buy on Kodiak Sciences, Maintains $58 Price Target

PRO
HC Wainwright & Co. Reiterates Buy on Kodiak Sciences, Maintains $58 Price Target

PRO
JP Morgan Maintains Overweight on Kodiak Sciences, Raises Price Target to $66

People Also Watch

People Also Watch

Kodiak Sciences Inc

ニュース

パートナーシップ

ベンジンガ・グローバル

Kodiak Sciences Analyst Price Targets

Recent Analyst Actions

Analyst Ratings News

PROUBS Maintains Buy on Kodiak Sciences, Raises Price Target to $120

PROHC Wainwright & Co. Maintains Buy on Kodiak Sciences, Raises Price Target to $96

PROGoldman Sachs Reinstates Neutral on Kodiak Sciences, Announces $36 Price Target

PROHC Wainwright & Co. Reiterates Buy on Kodiak Sciences, Maintains $58 Price Target

PROHC Wainwright & Co. Reiterates Buy on Kodiak Sciences, Maintains $58 Price Target

PROJP Morgan Maintains Overweight on Kodiak Sciences, Raises Price Target to $66

People Also Watch

People Also Watch

PRO
UBS Maintains Buy on Kodiak Sciences, Raises Price Target to $120

PRO
HC Wainwright & Co. Maintains Buy on Kodiak Sciences, Raises Price Target to $96

PRO
Goldman Sachs Reinstates Neutral on Kodiak Sciences, Announces $36 Price Target

PRO
HC Wainwright & Co. Reiterates Buy on Kodiak Sciences, Maintains $58 Price Target

PRO
HC Wainwright & Co. Reiterates Buy on Kodiak Sciences, Maintains $58 Price Target

PRO
JP Morgan Maintains Overweight on Kodiak Sciences, Raises Price Target to $66